Kentucky
Prescription drug spending and prescribing in Kentucky, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $5.0B for prescriptions written in Kentucky, the 20th most of 52 states and territories, and 4.5% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $5.0B
- Medicaid drugs, 2025: $2.8B
- Opioid share of claims: 4.5%
- Life-science raises, 2 years: $12M
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Kentucky | United States | Difference |
|---|---|---|---|
| Opioids | 4.5% | 3.5% | +26% |
| Antibiotics | 4.4% | 4.4% | 0% |
| Antipsychotics | 1.5% | 1.7% | -13% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Kentucky's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Promethazine Hcl | 3.1× | 79,650 |
| Levocetirizine Dihydrochloride | 2.9× | 132,345 |
| Buprenorphine Hcl/Naloxone Hcl | 2.9× | 102,104 |
| Roflumilast | 2.3× | 17,494 |
| Colestipol Hcl | 2.3× | 23,315 |
| Hydroxyzine Pamoate | 2.1× | 63,516 |
| Cariprazine Hcl | 2.0× | 29,390 |
| Naloxegol Oxalate | 2.0× | 12,842 |
| Cefdinir | 2.0× | 87,917 |
| Hydrocodone/Acetaminophen | 1.9× | 759,120 |
Biggest Medicaid Drugs
What Kentucky's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
7 Form D raises by companies based in Kentucky in the last two years; the 10 largest. See all raises- DesiCorp, Inc.$3M · Biotech · Apr 1, 2026
- Avana Health, Inc.$3M · Pharma · Dec 19, 2025
- Firefly Neuroscience, Inc.$2M · Other health care · Mar 13, 2026
- PCFM Investments, LLC$2M · Hospitals and physicians · Oct 28, 2026
- Visor Health Inc.$2M · Biotech · Sep 19, 2025
- PharmassetX Inc.$100K · Pharma · May 4, 2026
- PharmassetX Inc.$50K · Pharma · Oct 10, 2025
State Attorney General Health-Care Cases
Antitrust cases Kentucky joined, newest first; see every case- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)2019 · Pending
- California et al. v. Teikoku Seikayu Co.(Lidoderm), No. 3:18-cv-00675 (N.D. Cal. 01/31/18)2018 · Settled
- State of Wisconsin et al. v. Indivior, No. 16-5073 (E.D. Pa. Sept. 22,2016)2016 · Pending
- Connecticut et al. v. Teva Pharmaceuticals et al. Civ. Action No. (D.Conn. Dec. 15, 2016)2016 · Pending
- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
- Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)2006 · Settled
- State of Colorado et al v. Warner Chilcott, 1:05-cv-02182 (D.D.C.2005)2005 · Settled
- Maryland et al. v. Perrigo Company, No. 1:04CV01398 (D.D.C. Aug. 17, 2004)2004 · Settled
- Texas et al. v. Organon (Remeron), No. 04-5126 (D.N.J. 2004)2004 · Settled
Other States
Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia · Florida · Georgia · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Mississippi · Missouri · Montana · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oklahoma · Oregon · Pennsylvania · Puerto Rico · Rhode Island · South Carolina · South Dakota · Tennessee · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG